These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 16493453
1. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, Vidal O. Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453 [Abstract] [Full Text] [Related]
2. C-reactive protein is elevated in obese patients with the metabolic syndrome. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, Goldberg R. Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176 [Abstract] [Full Text] [Related]
3. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, Sowa P, Adamczyk-Sowa M, Kukla M, Berdowska A, Rehfeld JF, Bielanski W, Brzozowski T. J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025 [Abstract] [Full Text] [Related]
4. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Santos AC, Lopes C, Guimarães JT, Barros H. Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717 [Abstract] [Full Text] [Related]
5. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Quijada Z, Paoli M, Zerpa Y, Camacho N, Cichetti R, Villarroel V, Arata-Bellabarba G, Lanes R. Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788 [Abstract] [Full Text] [Related]
6. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [Abstract] [Full Text] [Related]
10. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan. Wu DM, Chu NF, Shen MH, Wang SC. Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764 [Abstract] [Full Text] [Related]
11. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S. Diabetes Metab Res Rev; 2007 Feb; 23(2):135-40. PubMed ID: 16770838 [Abstract] [Full Text] [Related]
16. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Aso Y, Wakabayashi S, Nakano T, Yamamoto R, Takebayashi K, Inukai T. Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835 [Abstract] [Full Text] [Related]
17. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence. Cizmecioglu FM, Etiler N, Ergen A, Gormus U, Keser A, Hekim N, Hamzaoglu O, Hatun S. Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):622-7. PubMed ID: 19235133 [Abstract] [Full Text] [Related]
19. Cardiovascular risk factors in obese women and their first-degree relatives. Saraç F, Ozgen AG, Yilmaz C, Tüzün M. Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331 [Abstract] [Full Text] [Related]
20. Metabolic syndrome and C-reactive protein among cardiology patients. Chapidze G, Dolidze N, Enquobahrie DA, Kapanadze S, Latsabidze N, Williams MA. Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]